Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 1Motor Activity 1Lung Neoplasms 1Inflammation 1

Interventions

Exercise 22Surveys and Questionnaires 3Resistance Training 3Diet 3Control Groups 3Nutrition Assessment 2Methods 2Interviews as Topic 2High-Intensity Interval Training 2Exercise Therapy 2Counseling 2pertuzumab 1pembrolizumab 1cytisine 1cemiplimab 1avelumab 1Weights and Measures 1Trastuzumab 1Therapeutics 1Telemedicine 1Standard of Care 1Spirometry 1Rehabilitation 1Psychiatric Rehabilitation 1Palliative Care 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Motor Activity × Spirometry × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡